We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Skeletal muscle vulnerability in a child with Pitt-Hopkins syndrome.
- Authors
Chiu, Celine; Küchler, Alma; Depienne, Christel; Preuße, Corinna; Marina, Adela Della; Reis, Andre; Kaiser, Frank J.; Nolte, Kay; Hentschel, Andreas; Schara-Schmidt, Ulrike; Kölbel, Heike; Roos, Andreas
- Abstract
Background: TCF4 acts as a transcription factor that binds to the immunoglobulin enhancer Mu-E5/KE5 motif. Dominant variants in TCF4 are associated with the manifestation of Pitt-Hopkins syndrome, a rare disease characterized by severe mental retardation, certain features of facial dysmorphism and, in many cases, with abnormalities in respiratory rhythm (episodes of paroxysmal tachypnea and hyperventilation, followed by apnea and cyanosis). Frequently, patients also develop epilepsy, microcephaly, and postnatal short stature. Although TCF4 is expressed in skeletal muscle and TCF4 seems to play a role in myogenesis as demonstrated in mice, potential myopathological findings taking place upon the presence of dominant TCF4 variants are thus far not described in human skeletal muscle. Method: To address the pathological effect of a novel deletion affecting exons 15 and 16 of TCF4 on skeletal muscle, histological and immunofluorescence studies were carried out on a quadriceps biopsy in addition to targeted transcript studies and global proteomic profiling. Results: We report on muscle biopsy findings from a Pitt-Hopkins patient with a novel heterozygous deletion spanning exon 15 and 16 presenting with neuromuscular symptoms. Microscopic characterization of the muscle biopsy revealed moderate fiber type I predominance, imbalance in the proportion of fibroblasts co-expressing Vimentin and CD90, and indicate activation of the complement cascade in TCF4-mutant muscle. Protein dysregulations were unraveled by proteomic profiling. Transcript studies confirmed a mitochondrial vulnerability in muscle and confirmed reduced TCF4 expression. Conclusion: Our combined findings, for the first time, unveil myopathological changes as phenotypical association of Pitt-Hopkins syndrome and thus expand the current clinical knowledge of the disease as well as support data obtained on skeletal muscle of a mouse model.
- Subjects
SKELETAL muscle; TRANSCRIPTION factors; FACIAL abnormalities; SHORT stature; SYNDROMES in children; HYPERVENTILATION; CYANOSIS
- Publication
Skeletal Muscle, 2024, Vol 14, Issue 1, p1
- ISSN
2044-5040
- Publication type
Article
- DOI
10.1186/s13395-024-00348-0